The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of ...

Amide Technologies has raised $16.5 million in venture capital to help commercialize its peptide production process. The process was developed from 2011 to 2017 in the lab of the Massachusetts ...

There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...

Producing the drugs is a dirty process ...

The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients ...

The PurePep ® Sonata ® is a mid-pilot scale peptide synthesizer that has been designed to provide more reliable and robust workflows. PurePep Sonata introduces real-time flow technology to streamline ...

The peptide synthesis market is expanding due to growing demand for peptide-based therapeutics, driven by superior target specificity and lower toxicity. Innovations like microwave-assisted SPPS ...

CordenPharma says it is implementing continuous process manufacturing of peptides at its plant in Frankfurt, Germany, in collaboration with PeptiSystems, a Swedish developer of manufacturing ...

The field of peptides is exploding, Perpetual Medicines Corp. co-founder, chairman and CEO Kerry L. Blanchard recently told BioWorld, “with a projected growth rate far surpassing large and small ...

Peptide bonds represent a cornerstone in molecular biology. They act as essential chemical linkages that bind amino acids into complex chains, ultimately forming peptides and proteins. These ...